These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29667584)

  • 1. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.
    Bosma BE; van den Bemt PMLA; Melief PHGJ; van Bommel J; Tan SS; Hunfeld NGM
    Neth J Med; 2018 Apr; 76(3):115-124. PubMed ID: 29667584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
    Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
    Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a pharmacist on post-take ward round prescribing and medication appropriateness.
    Bullock B; Donovan P; Mitchell C; Whitty JA; Coombes I
    Int J Clin Pharm; 2019 Feb; 41(1):65-73. PubMed ID: 30610543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' acceptance of pharmacists' interventions in daily hospital practice.
    Zaal RJ; den Haak EW; Andrinopoulou ER; van Gelder T; Vulto AG; van den Bemt PMLA
    Int J Clin Pharm; 2020 Feb; 42(1):141-149. PubMed ID: 32026348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
    Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
    J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
    Chen CC; Hsiao FY; Shen LJ; Wu CC
    Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacist clinical interventions in a Dutch hospital setting.
    Bosma L; Jansman FG; Franken AM; Harting JW; Van den Bemt PM
    Pharm World Sci; 2008 Jan; 30(1):31-8. PubMed ID: 17592752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit.
    Bourne RS; Choo CL
    Int J Clin Pharm; 2012 Apr; 34(2):351-7. PubMed ID: 22354852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.
    Gallagher J; Byrne S; Woods N; Lynch D; McCarthy S
    BMC Health Serv Res; 2014 Apr; 14():177. PubMed ID: 24742158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital.
    Claus BO; Vandeputte FM; Robays H
    Int J Clin Pharm; 2012 Oct; 34(5):773-8. PubMed ID: 22810891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and economic impact of the pharmacy resident incorporation into the healthcare team].
    Arroyo Conde C; Aquerreta I; Ortega Eslava A; Goñi Zamarbide O; Giráldez Deiró J
    Farm Hosp; 2006; 30(5):284-90. PubMed ID: 17166062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
    Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
    BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an automated surveillance system using trigger alerts to prevent adverse drug events in the intensive care unit and general ward.
    DiPoto JP; Buckley MS; Kane-Gill SL
    Drug Saf; 2015 Mar; 38(3):311-7. PubMed ID: 25711668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy.
    Lombardi N; Wei L; Ghaleb M; Pasut E; Leschiutta S; Rossi P; Troncon MG
    BMC Health Serv Res; 2018 Apr; 18(1):259. PubMed ID: 29631587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.